Q: Comments on earnings?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
Invitae Corporation (NVTA)
-
CRISPR Therapeutics AG (CRSP $53.84)
-
Twist Bioscience Corporation (TWST $35.32)
-
ARK Genomic Revolution ETF (ARKG $30.55)
Q: I currently own some ARKG and CRSP. If you were to buy a few more individual stocks in this space and had a long term time frame and high risk tolerance what would you buy?
Q: Hi,
Your views on BAX-N on long term. Do you prefer any other name over BAX-N in health sector?
Thanks
Piyush
Your views on BAX-N on long term. Do you prefer any other name over BAX-N in health sector?
Thanks
Piyush
Q: While just about everything is taking a beating today, DOC is up over 8% today on more than twice the average daily volume......Any news? I'm not seeing anything.
Thanks
Dave
Thanks
Dave
Q: PLX is an Israeli Bio co. not showing in your system.
I bought a small position 6 months ago as I am very interested in the diseases they are working to try to alleviate and potentially cure. It has gone up in price nicely this week after company update to shareholders.
Would appreciate your views. Is this a hold or worth buying more at this stage. John.
I bought a small position 6 months ago as I am very interested in the diseases they are working to try to alleviate and potentially cure. It has gone up in price nicely this week after company update to shareholders.
Would appreciate your views. Is this a hold or worth buying more at this stage. John.
Q: In response to your answer to Richard on Reliq, according to the company website, from a corporate presentation document, “management and other insiders” at the Company own 8% of the outstanding shares.
Q: I have 25000 shares of this co. What do you think of it?
Q: do you see any chance of a recovery for these two stocks, or best just to move on? they are in a RRSP account so no chance for tax loss.
thanks Dave
thanks Dave
Q: Hello Peter, Ryan, and 5i Team,
I know you haven't been a big fan of these two companies in the past, due to some questionable management issues before they split from Patient Home Monitoring. However, Viemed shares have surged since listing on the Nasdaq (with some help from Covid) and PTQ has shown recent momentum with last week's announcement of a pending Nasdaq listing. Could you please give me your current thoughts on these two companies? Specifically, does the potential for a cross-listing gain with PTQ outweigh some of the other concerns, or would you still be wary? Thanks, Brad
I know you haven't been a big fan of these two companies in the past, due to some questionable management issues before they split from Patient Home Monitoring. However, Viemed shares have surged since listing on the Nasdaq (with some help from Covid) and PTQ has shown recent momentum with last week's announcement of a pending Nasdaq listing. Could you please give me your current thoughts on these two companies? Specifically, does the potential for a cross-listing gain with PTQ outweigh some of the other concerns, or would you still be wary? Thanks, Brad
-
CRISPR Therapeutics AG (CRSP $53.84)
-
Twist Bioscience Corporation (TWST $35.32)
-
Beam Therapeutics Inc. (BEAM $27.55)
Q: Hello team,
Of the 3 companies above, BEAM has 3 times more shares sold short (18% of the float) but all three have been on a run.
If you could buy only one which one would you choose today as a great company for a long-term hold and which one you would rather avoid? And of course why?
Thanks for making investment accessible for ordinary people.
Of the 3 companies above, BEAM has 3 times more shares sold short (18% of the float) but all three have been on a run.
If you could buy only one which one would you choose today as a great company for a long-term hold and which one you would rather avoid? And of course why?
Thanks for making investment accessible for ordinary people.
Q: Can you please give me your view on these two stocks. There has not been too many questions on them on your list.. Speculative, is there a future, etc.
-
Illumina Inc. (ILMN $141.07)
-
Invitae Corporation (NVTA)
-
CRISPR Therapeutics AG (CRSP $53.84)
-
Twist Bioscience Corporation (TWST $35.32)
Q: In your answer to a question recently asked on Genomics, your suggestion was to buy an ETF such as ARKG or EAGB. You also mentioned that if so inclined you could start adding small amounts in specific stocks which of course be riskier. Would you be able to suggest 3 or 4 of these stocks either US or Canadian, preferably at least one of each.
Q: Comments on SIS, please.
I see the x div date is Dec 30, when is the next one? I'm think of taking some gains and maybe picking it back up when it gets boring again.
I see the x div date is Dec 30, when is the next one? I'm think of taking some gains and maybe picking it back up when it gets boring again.
Q: Here is a good presentation on Sernova from the president. It touches on market size. Talks about potentials revenue streams and their thoughts on market sizing. A fun number was "untapped $2B market". I'm in since 0.42.
https://journey.ct.events/view/3a577711-041b-48a3-8b1c-0d47129bb30c
The two big ones:
- Type 1 diabetes
- Hyperthyroidism and Hashimoto's
https://journey.ct.events/view/3a577711-041b-48a3-8b1c-0d47129bb30c
The two big ones:
- Type 1 diabetes
- Hyperthyroidism and Hashimoto's
Q: what are your thoughts on this company
-
Intuitive Surgical Inc. (ISRG $586.24)
-
Medtronic plc. (MDT $97.53)
-
Stryker Corporation (SYK $367.54)
Q: I am interested in investing in Health Care Robotics. I am looking at Stryker and Medtronic. I am leaning toward MDT due to lower entry point and higher dividend. Based on history and statistics which one would you favour? Could you suggest similar companies for consideration?
Thank You
Jane
Thank You
Jane
-
Amgen Inc. (AMGN $326.10)
-
AbbVie Inc. (ABBV $220.08)
-
Pfizer Inc. (PFE $25.48)
-
Bausch Health Companies Inc. (BHC $10.33)
Q: Looking at buying some healthcare...will this one recover or are there better choices in U or Can?...
Q: Given todays news how does one go about valuing the company. The news seems very positive.
Q: Hi Team,
A couple different parts to this question. The "Geno" sector has exploded this year. Different hot names in the sector seem to be moving 10-20% daily. I have buddies now piling into these names now, so am wondering if maybey there's a "top" coming here soon? Or if you think this Euphoria will continue in the sector? To me it almost feels like gambling to try to buy in to these things right now. Also on this topic, can you briefly give your thoughts on what has made the Geno sector suddenly start to move this year? Its not like geno work is a new thing...or is it just hitting some major progress this year? Same can be said for the EV sector. For fear of "missing out" I am tempted to sell KXS out of my rsp for a slight gain as I hold this name in 2 different accounts to raise funds to buy EAGB (the canadian version of ARKG). My portfolio is currently heavy weighted tech and I currently have no Geno exposure. Is EAGB the best way for me to play this sector long term, or do you have any explosive individual GENO names you would recommend buying for a multi bagger possibility? I have heard BNGO has some good things coming its way? .....Or should I wait for a pullback in the massive run up before I think about doing this...or not at all? If I did buy EAGB I would probably buy and hold it for years as a way to play the sector. It does seem like there could be some major breakthroughs down the road in geno technology.
A couple different parts to this question. The "Geno" sector has exploded this year. Different hot names in the sector seem to be moving 10-20% daily. I have buddies now piling into these names now, so am wondering if maybey there's a "top" coming here soon? Or if you think this Euphoria will continue in the sector? To me it almost feels like gambling to try to buy in to these things right now. Also on this topic, can you briefly give your thoughts on what has made the Geno sector suddenly start to move this year? Its not like geno work is a new thing...or is it just hitting some major progress this year? Same can be said for the EV sector. For fear of "missing out" I am tempted to sell KXS out of my rsp for a slight gain as I hold this name in 2 different accounts to raise funds to buy EAGB (the canadian version of ARKG). My portfolio is currently heavy weighted tech and I currently have no Geno exposure. Is EAGB the best way for me to play this sector long term, or do you have any explosive individual GENO names you would recommend buying for a multi bagger possibility? I have heard BNGO has some good things coming its way? .....Or should I wait for a pullback in the massive run up before I think about doing this...or not at all? If I did buy EAGB I would probably buy and hold it for years as a way to play the sector. It does seem like there could be some major breakthroughs down the road in geno technology.
Q: Hi Gang
Can you give us your take on xrx
Thanks Mike B
Can you give us your take on xrx
Thanks Mike B